24 November 2024

Starpharma to present at ASX CEO Session

Melbourne, Australia; 17 May 2016: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) is presenting today at The CEO Session Series event in Sydney.

 

The CEO Sessions is hosted by the ASX in conjunction with Finance News Network (FNN) and is designed to engage with the investment community - bringing together ASX-listed companies, investors, and financial market participants.

 

“Starpharma welcomes this opportunity to present a brief overview of the Company’s products and plans. This is a terrific opportunity to also highlight Starpharma’s recent development.” said CEO Dr Fairley.

 

For investors unable to attend The CEO Sessions in person, the presentation is being filmed and will be available across FNN and ASX's wide distribution channels.

 

View Presentation: ASX CEO Session Presentation May 2016 ( pdf file, 1MB)

Watch Presentation:  ASX CEO Session Presentation May 2016 (website link)

Download Announcement: Starpharma to present at ASX CEO Session (pdf file, 80kb)

This contains certain forward-looking statements.

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.